PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome

NCT02187250 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

PCOS
Obesity

Interventions

DRUG: metformin
DRUG: liraglutide
DRUG: roflumilast

Sponsor

University Medical Centre Ljubljana